DarioHealth (Formerly Known As LabStyle Innovations)
Gibor Sport Tower
7 Menachem Begin Street
About DarioHealth (Formerly Known As LabStyle Innovations)DarioHealth Corp. (NASDAQ: DRIO) creates innovative mobile and digital tools that empower and engage users to lead healthier lives. DarioHealth’s “Real time. Real data. Real people” approach and strategy is positioning the company as a major player in the mHealth industry; an industry currently worth $10B and expected to reach $31B by 2020*. DarioHealth’s flagship product, the Dario™ Smart Diabetes Management Solution, is a platform for diabetes management that combines an all-in-one blood glucose meter, native smart phone app (iOS & Android), website portal and a wide variety of treatment tools to support more proactive and better informed decisions by users living with diabetes, their doctors and healthcare systems.
The Dario Smart Diabetes Management Solution was granted U.S. FDA marketing clearance in December 2015 and is set to launch in the current quarter in the U.S. – the largest market in the world for glucose monitoring. LabStyle has been granted patents, and is pursuing additional applications - in multiple areas covering the specific processes related to blood glucose level measurement, as well as more general methods for rapid body fluids testing using mobile devices and cloud-based services. Dario™ is currently available in the UK, New Zealand, Netherlands, Australia, Israel, Canada, Belgium and Italy. Dario received reimbursement coverage in the UK, Australia, Israel, Italy and Canada. Sequential quarterly revenues are growing rapidly, reflecting strong market adoption.
CEO: Erez Raphael
CFO: Zvi Ben-David
114 articles with DarioHealth (Formerly Known As LabStyle Innovations)
DarioHealth Signs National Distribution Deal in the U.S. With Better Living Now for Its Digital Health Products
BLN will purchase DarioHealth's products including the Dario smart glucose meter and test strips for distribution to its customers.
DarioHealth to Offer Diabetes Content and Coaching to Patients in Canada in Collaboration With LMC Healthcare, Canada's Largest Diabetes and Endocrinology Specialist Care Provider
DarioHealth's Digital Diabetes Content and Coaching, powered by LMC, to be made available across Canada starting in Q12019
Earnings and business update call scheduled for 9:00 am ET today
DarioHealth's Digital Diabetes Platform to be Made Available to 4.6 Million Customers at Giant Eagle, One of America's Largest Supermarket Chains
Millions of Customers Will Be Able to Sign Up for Online Education and Rewards through the DarioHealth Blood Glucose Monitoring System and Smartphone Application. [12-November-2018] CAESAREA, Israel , Nov. 12, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today it h
DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced that it will release its third quarter 2018 results on Tuesday, November 13, and host a conference call the same morning at 9:00am EDT
DarioHealth's Digital Health Blood Glucose Monitoring System Compatible With New iPhone XS and XS Max
Analyst estimates 75-80 Million iPhone Shipments in 2H 2018
DarioHealth Appoints Glen D. Moller, Healthcare Executive, Investor and Former CEO of ArroHealth, to Its Board of Directors
DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Glen Moller has joined the Company's Board of Directors.
Call to review recent fundraise, expected accelerated growth, and introduce new President and new Chairman
DarioHealth Appoints Olivier Jarry, Former Head of Diabetes Care at Bayer and Executive at Novartis and Bristol-Myers-Squibb, as President and Chief Commercial Officer
DarioHealth Corp. announced today that Olivier Jarry, a prominent global life sciences and consumer health executive, has joined the Company as President and Chief Commercial Officer.
DarioHealth Chosen by Attain Health for Pilot Study to Improve Cystic Fibrosis Related Diabetes Management
Opportunity for DarioHealth to take early lead in deploying digital health solution for this unique form of diabetes common in people with cystic fibrosis
DarioHealth to Exhibit at American Association of Diabetes Educators Conference on August 17-20 in Baltimore
DarioEngage diabetes coaching platform to be introduced and launched to over 3,000 diabetes educators attending the conference
Record Q2 2018 revenue of $2.06 million marks 70% growth year over year
Earnings and Business Update Conference Call Scheduled for 9:00am EDT
DarioHealth Corp. announced that Research2Guidance, an analyst and strategic consulting company for the digital health industry, published an interview of DarioHealth CEO, Erez Raphael titled "Using real-time data to feed predictive care models for diabetes management."
DarioHealth Appoints Healthcare Technology Entrepreneur and Venture Capital Partner Yoav Shaked as Chairman of the Board
DarioHealth Corp. announced Yoav Shaked has joined the Company as Chairman of the Board.
DarioHealth Corp. announced that its stock will be added to the Russell Microcap® Index
DarioHealth Provides Update on Recently Launched iPhone 7, 8 and X Smart Glucose Meter in the U.S. Following FDA Clearance
DarioHealth Reveals First Indication of U.S. Market Opportunity
Earnings and Business Update Conference Call Scheduled for 9:00am EDT [02-May-2018] DarioHealth to Host First Quarter 2018 Conference Call on May 15, 2018 Earnings and Business Update Conference Call Scheduled for 9:00am EDT NEW YORK and CAESAREA, Israel, May 2, 2018 /PRNewswire
DarioHealth Corp. announced it has hired U.S.-based digital health executive JC Muyl as Head of Commercialization North America to head up the Company's business-to-business sales of the Dario Engage platform.
DarioHealth Corp. announced that the United States Food and Drug Administration (FDA) has granted Pre-market Notification (510(k)) clearance for the Company's Lightning®-enabled version of the acclaimed Dario™ Blood Glucose Monitoring System which enables the use of the Dario app on iPhone 7, 8 and X smart mobile devices (SMD).